Otsuka Pharmaceutical Co., Ltd.
Clinical trials sponsored by Otsuka Pharmaceutical Co., Ltd., explained in plain language.
-
New eczema foam shows promise for kids in Late-Stage trial
Disease control Not yet recruitingThis Phase 3 trial tests a medicated foam called OPA-15406 (difamilast) for atopic dermatitis (eczema) in children aged 2 and older, and infants under 2. About 198 participants will apply the foam twice daily for 8 weeks. The main goal is to see if the foam clears or nearly clear…
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New eczema foam shows promise in Late-Stage trial
Disease control Not yet recruitingThis Phase 3 trial tests a medicated foam called OPA-15406 (difamilast) for adults with atopic dermatitis, a common skin condition causing red, itchy rashes. About 156 participants will apply the foam or a placebo twice daily for 4 weeks. The goal is to see if the foam clears or …
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:58 UTC